SILK - Silk Road Medical, Inc
After hours:
Chart Events
Fast Stochastic
Performance Outlook
- Short Term2W - 6W
- Mid Term6W - 9M
- Long Term9M+
| Previous Close | 31.64 |
| Open | 31.51 |
| Bid | 31.61 x 800 |
| Ask | 31.59 x 800 |
| Day's Range | 31.21 - 32.65 |
| 52 Week Range | 28.98 - 58.04 |
| Volume | |
| Avg. Volume | 611,114 |
| Market Cap | 1.217B |
| Beta (5Y Monthly) | 1.17 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.44 |
| Earnings Date | Jul 24, 2023 - Jul 28, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 46.00 |
Fair Value
Related Research
Insider MonkeyHere’s Why Silk Road Medical (SILK) Declined in Q1
Baron Funds, an investment management company, released its “Baron Discovery Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. The fund was up 11.20% in the first quarter compared to the Russell 2000 Growth Index’s return of 6.07%. The strong performance of holdings in the Information Technology (IT), Industrials, and […]
ZacksSilk Road Medical (SILK) Reports Q1 Loss, Lags Revenue Estimates
Silk Road Medical (SILK) delivered earnings and revenue surprises of -10.26% and 1.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswireSilk Road Medical Reports First Quarter 2023 Financial Results
SUNNYVALE, Calif., May 09, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended March 31, 2023. “2023 is off to a strong start as we execute against our U.S. commercial opportunity, including optimizing and expanding our field presence to meet strong TCAR demand,” said Erica Rogers, CEO of Silk Road Medical. “We also achieved multiple regulatory and
Simply Wall St.With Silk Road Medical, Inc (NASDAQ:SILK) It Looks Like You'll Get What You Pay For
Silk Road Medical, Inc's ( NASDAQ:SILK ) price-to-sales (or "P/S") ratio of 11.9x might make it look like a strong sell...
GlobeNewswireSilk Road Medical Receives 2023 Great Place To Work Certification™
SUNNYVALE, Calif., May 05, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that it has been Certified™ by Great Place To Work® for the 3rd year in a row. The prestigious award is based entirely on what current employees say about their experience working at Silk Road Medical. This year, 97% of employees said Silk Road Medical is a great place to work – a full 40 points higher than the av
- GlobeNewswire
Silk Road Medical Announces Investor Education Webcast with Key Opinion Leaders
SUNNYVALE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that the company will host an investor education webcast at 11:00 a.m. Eastern Time on Thursday, May 25, 2023. The event represents the first in a series of webcasts being organized by the company to educate investors on TCAR and the treatment of carotid artery disease. The event will include a discussion between
- GlobeNewswire
Silk Road Medical to Present at the BofA Securities 2023 Healthcare Conference
SUNNYVALE, Calif., April 26, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will participate in the upcoming BofA Securities 2023 Healthcare Conference. Management is scheduled to present on Wednesday, May 10, 2023 at 4:20 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: h
- GlobeNewswire
Silk Road Medical to Report First Quarter 2023 Financial Results on May 9, 2023
SUNNYVALE, Calif., April 18, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the first quarter 2023 after market close on Tuesday, May 9th, 2023. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Those interested in listening to the conference call should register online using this
TheStreet.comDoes Silk Road Medical Have a Smooth Path Forward?
Silk Road Medical was rated a new fundamental "buy" at sell-side firm B. Riley on Friday. The company is focused on reducing the risk of stroke and it has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a minimally invasive procedure that can clear blockages and open a narrowed carotid artery.
- Simply Wall St.
While Silk Road Medical (NASDAQ:SILK) shareholders have made 17% in 3 years, increasing losses might now be front of mind as stock sheds 8.4% this week
Silk Road Medical, Inc ( NASDAQ:SILK ) shareholders might be concerned after seeing the share price drop 28% in the...
Insider MonkeySilk Road Medical, Inc (NASDAQ:SILK) Q4 2022 Earnings Call Transcript
Silk Road Medical, Inc (NASDAQ:SILK) Q4 2022 Earnings Call Transcript February 28, 2023 Operator: Good day, and thank you for standing by. Welcome to the Fourth Quarter 2022 Silk Road Medical Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Please be […]
- Thomson Reuters StreetEvents
Q4 2022 Silk Road Medical Inc Earnings Call
Q4 2022 Silk Road Medical Inc Earnings Call
ZacksSilk Road Medical (SILK) Reports Q4 Loss, Tops Revenue Estimates
Silk Road Medical (SILK) delivered earnings and revenue surprises of 8.11% and 7.40%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Silk Road Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Financial Outlook
SUNNYVALE, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months and full year ended December 31, 2022. “Our fourth quarter closes the books on a remarkable year for Silk Road Medical,” said Erica Rogers, President and Chief Executive Officer. “We are well positioned to drive strong growth and category leadership while building upon the op
- GlobeNewswire
Silk Road Medical to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023
SUNNYVALE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced it will report financial results for the fourth quarter and full year 2022 after market close on Tuesday, February 28th, 2023. Company management will host a corresponding audio webcast beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time. Those interested in listening to the conference call should regist
ZacksWhat Makes Silk Road Medical (SILK) a New Strong Buy Stock
Silk Road Medical (SILK) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Insider MonkeySilk Road Medical, Inc (NASDAQ:SILK) Q3 2022 Earnings Call Transcript
Silk Road Medical, Inc (NASDAQ:SILK) Q3 2022 Earnings Call Transcript November 11, 2022 Operator: Good day, and thank you for standing by. Welcome to the Silk Road Medical 2022 Third Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. Please […]
- GlobeNewswire
Silk Road Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference
SUNNYVALE, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare Conference. Silk Road Medical’s management is scheduled to present on Tuesday, January 10, 2023 at 4:30 p.m. Pacific Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section o
Insider MonkeyIs Silk Road Medical (SILK) a Great Stock to Invest in?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small/Mid Cap Growth Strategy” third-quarter investor letter. A copy of the same can be downloaded here. In the third quarter, the strategy outperformed the Russell 2500 Growth Index and returned 0.22% (net), and the index return was -0.12%. During the quarter, weakness in Financials, Health […]
Insider MonkeyHere’s What Makes Silk Road Medical (SILK) a Strong Stock
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Ultra Strategy” third-quarter 2022 investor letter. A copy of the same can be downloaded here. The strategy underperformed its benchmark index, the Russell 2000 Growth Index, in the third quarter. News of continuous interest rate hikes from the federal reserve negatively impacted growth companies’ […]
ZacksSilk Road Medical (SILK) is a Great Momentum Stock: Should You Buy?
Does Silk Road Medical (SILK) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Simply Wall St.
Silk Road Medical Third Quarter 2022 Earnings: Beats Expectations
Silk Road Medical ( NASDAQ:SILK ) Third Quarter 2022 Results Key Financial Results Revenue: US$37.4m (up 51% from 3Q...
ZacksSilk Road Medical (SILK) Reports Q3 Loss, Tops Revenue Estimates
Silk Road Medical (SILK) delivered earnings and revenue surprises of 34.09% and 10.44%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Silk Road Medical Reports Third Quarter 2022 Financial Results
SUNNYVALE, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2022. “Our performance in the third quarter reflects broad-based U.S. TCAR strength as we capitalize on the operational infrastructure our team has worked so hard to establish,” said Erica Rogers, CEO of Silk Road Medical. “This is the first time in over s
- GlobeNewswire
Silk Road Medical to Present at Upcoming Investor Conferences
SUNNYVALE, Calif., Nov. 03, 2022 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that management will present at the following investor conferences. Stifel 2022 Healthcare Conference Presentation on Tuesday, November 15 at 10:20 a.m. Eastern Time 4th Annual Wolfe Research Healthcare Conference Presentation on Wednesday, November 16 at 1:20 p.m. Eastern Time 34th Annual Piper Sandler Healthcar
